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The control of M. tuberculosis infection occurs 
through  an  acquired  antigen-specific  CD4+  
T cell response and the IL12B gene is essential 
to this response (Cooper et al., 2007; Cooper, 
2009). Although IL-12 plays an expected role 
in modulating Th1 responses to M. tuberculosis, 
we  have  also  shown  that  IL-12(p40)2  is   
required  for  DCs  to  migrate  in  response  to 
chemokines  after  exposure  to  mycobacterial 
and  other  pathogenic  stimuli  (Khader  et  al., 
2006; Robinson et al., 2008). That this migra-
tion may be important in initiating T cell re-
sponses  is  suggested  by  the  observation  that 
depletion of CD11c+ cells before infection de-
lays T cell activation and influences the out-
come of infection (Tian et al., 2005).
IL-12 family members mediate their bio-
logical activities through specific, high-affinity 
dimeric receptors. All these receptors share   
IL-12R1, a 100-kD glycosylated protein that 
spans the plasma membrane and serves as a 
low-affinity receptor for the IL-12p40 subunit 
of IL-12 family members (Chua et al., 1994, 
1995); coexpression with IL-12R2 or IL-23R 
results  in  high-affinity  binding  of  IL-12  and   
IL-23,  respectively,  and  confers  biological   
responsiveness to these cytokines (Presky et al., 
1996;  van  Rietschoten  et  al.,  2000;  Parham   
et  al.,  2002).  Polymorphisms  in  IL12B  or 
IL12RB1 are associated with psoriasis (Capon 
et al., 2007), atopic dermatitis, and other allergic 
phenotypes  (Takahashi  et  al.,  2005)  and,   
importantly, nonfunctional IL12RB1 alleles 
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RNA splicing is an increasingly recognized regulator of immunity. Here, we demonstrate 
that after Mycobacterium tuberculosis infection (mRNA) il12rb1 is spliced by dendritic 
cells (DCs) to form an alternative (mRNA) il12rb1tm that encodes the protein  
IL-12R1TM. Compared with IL-12R1, IL-12R1TM contains an altered C-terminal 
sequence and lacks a transmembrane domain. Expression of IL-12R1TM occurs in 
CD11c+ cells in the lungs during M. tuberculosis infection. Selective reconstitution of 
il12rb1/ DCs with (mRNA) il12rb1 and/or (mRNA) il12rb1tm demonstrates that  
IL-12R1TM augments IL-12R1-dependent DC migration and activation of  
M. tuberculosis-specific T cells. It cannot mediate these activities independently of 
IL12R1. We hypothesize that M. tuberculosis-exposed DCs express IL-12R1TM to 
enhance IL-12R1-dependent migration and promote M. tuberculosis–specific T cell  
activation. IL-12R1TM thus represents a novel positive-regulator of IL12R1- 
dependent DC function and of the immune response to M. tuberculosis.
©  2010  Robinson  et  al.  This  article  is  distributed  under  the  terms  of  an   
Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six 
months after the publication date (see http://www.rupress.org/terms). After six 
months it is available under a Creative Commons License (Attribution–Noncom-
mercial–Share Alike 3.0 Unported license, as described at http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
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RESULTS
IL-12R1 is required for M. tuberculosis–induced  
DC migration and function
As il12b is required for DC migration in response to M. tuber-
culosis (Khader et al., 2006), it was necessary to determine 
whether il12rb1, which encodes the receptor for IL-12 
(Presky et al., 1998; Wang et al., 1999; Oppmann et al., 2000), 
is expressed by DCs in response to M. tuberculosis and if it is   
required for subsequent DC migration and T cell priming. To 
do this, we delivered M. tuberculosis via the intratracheal route 
and  found  that  the  frequency  of  CD11c+  cells  expressing   
IL-12R1 in the lungs increases 3 h after delivery (Fig. 1 A); 
BM-derived DCs (BMDCs) also respond to M. tuberculosis by 
increasing the expression of IL-12R1 on CD11c+ cells   
(Fig. 1 B). To test if il12rb1 was required for DC migration   
after  mycobacterial  stimulation,  we  generated  an  immature 
population of il12rb1/ BMDCs and tested its ability to   
migrate toward the homeostatic chemokine CCL19 using a 
previously established method (Khader et al., 2006). il12rb1/ 
DCs  are  morphologically  and  phenotypically  similar  to 
C57BL/6 DCs (unpublished data); however, in an in vitro 
transwell assay, il12rb1/ DCs had a significantly lower   
migratory response toward CCL19 after exposure to varying 
predispose to mycobacterial susceptibility (Altare et al., 1998; 
de Jong et al., 1998; Filipe-Santos et al., 2006; Fortin et al., 
2007). Thus, understanding how IL-12R1 expression and 
IL-12R1–dependent  signaling  is  regulated  has  important 
implications for tuberculosis and may impact other diseases.
Given that CD11c+ cells contribute to the control of   
M. tuberculosis infection (Tian et al., 2005) and that IL-12(p40)2 
is required for their migration in response to pathogenic stimuli 
(Khader et al., 2006; McCormick et al., 2008; Robinson et al., 
2008), we sought to determine if IL-12R1 is required for DC 
migration after exposure to this organism. In the course of 
these investigations we not only confirmed this hypothesis but 
also discovered that DCs express both IL-12R1 and a novel 
IL-12R1 splice variant (IL-12R1TM) in response to   
M. tuberculosis. This splice variant can be seen at the mRNA 
level in CD11c+ cells from the lungs of M. tuberculosis–infected 
mice and as a protein in the membrane of DCs. Importantly, 
we have determined that IL-12R1TM functions to en-
hance  IL-12R1–dependent  DC  migration  and  promote 
CD4+ T cell activation. This finding not only impacts our un-
derstanding of DC migration and IL-12R1–dependent   
mycobacterial immunity it also reveals a previously unknown 
positive regulator of IL-12R1–dependent events.
Figure 1.  IL-12R1 is required for M. tuberculosis–induced DC migration. (A) M. tuberculosis was instilled into the trachea of C57BL/6 mice, and 3 h 
later the frequency of CD11c+IL-12R1+ cells in the lungs was determined. Dot plots are representative of four mice per condition; this experiment was per-
formed twice with two separate BM preparations. (B) C57BL/6 BMDCs were exposed to M. tuberculosis or media alone, and 3 h later the frequency of 
CD11c+IL-12R1+ cells was determined. Dot plots represent the same BMDC preparation stimulated with either condition and are representative of three 
separate experiments. (C) BMDCs generated from C57BL/6 or il12rb1/ mice were assayed for their ability to migrate to CCL19 in a transwell assay after a  
3-h exposure to M. tuberculosis (CI, number moved in response to CCL19/number moved to media alone). Data points in C represent mean and SD of triplicate 
values and are representative of three separate experiments; for the difference between CI induced in C57BL/6 relative to il12rb1/ DCs, *, P < 0.05; **, P < 
0.005, as determined by Student’s t test. (D–F) M. tuberculosis/CFSE was instilled via the trachea into C57BL/6, il12b/, il12rb1/, or il12rb2/ mice. 18 h 
later, the frequency (D and E) and total number of CD11c+CFSE+ cells in the draining MLN were counted. The data points in E and F represent the mean and SD 
of combined data from four mice per group (F) and are representative of two separate experiments; for the difference between percentage and/or number of 
CD11c+CFSE+ cells found in C57BL/6 mice relative to il12b/ or il12rb1/ mice, *, P < 0.05; ***, P < 0.0005, as determined by Student’s t test.JEM VOL. 207, March 15, 2010 
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concentrations  of  M.  tuberculosis  compared  with  C57BL/6 
controls (Fig. 1 C). To determine if this was also true in 
vivo, we administered a mixture of M. tuberculosis and CFSE 
to il12b/, il12rb1/, il12rb2/, and C57BL/6 mice via the 
trachea and the number of CFSE+ CD11c+ cells in the drain-
ing  mediastinal  LN  (MLN)  was  determined  18  h  later.   
Although nonmanipulated mice of all genotypes had similar 
amounts  of  CD11c+  cells  in  their  lung  and  MLN  (not   
depicted), we consistently observed a lower frequency (Fig. 1, 
D and E) and fewer numbers (Fig. 1 F) of CD11c+CFSE+ cells 
in the MLN of il12b/ and il12rb1/ mice after administra-
tion via the trachea of M. tuberculosis and CFSE. This was   
not true of il12rb2/ mice, further supporting a role for 
IL-12(p40)2, and not IL-12p70, in DC migration (Khader 
et al., 2006). These results demonstrate that il12rb1 is re-
quired for M. tuberculosis–induced CD11c+ cell migration from 
the lung to the draining MLN.
A reduced frequency of il12rb1-sufficient CD11c+ cells  
in the lung delays the activation of M. tuberculosis–specific 
T cells
CD4+ T cell responses to M. tuberculosis antigens are initiated 
in the MLN (Gallegos et al., 2008; Reiley et al., 2008; 
Winslow et al., 2008; Wolf et al., 2008). Therefore, we spec-
ulated that a delay in CD11c+ cell migration would delay 
the activation of M. tuberculosis–specific CD4+ T cells. To 
test this idea, we used diphtheria toxin (DT) to specifically   
deplete il12rb1+/+ CD11c+ cells from BM chimeras that con-
tained  DT  receptor–positive  (DTR+)  C57BL/6  CD11c+ 
cells and DTR-negative il12rb1/ CD11c+ cells and mea-
sured M. tuberculosis–specific T cell activation to intratracheal 
administration of M. tuberculosis and antigen. The chimeras 
were generated by reconstituting lethally irradiated C57BL/6 
mice with 25% il12rb1/ and 75% Itgax-DTR/eGFP BM 
(DTR:il12rb1/ mice) or, as a control, 25% C57BL/6 and 
75% Itgax-DTR/EGFP BM (DTR:WT mice). The Itgax-
DTR/eGFP mice are transgenic for a simian DTR fused to 
an enhanced GFP (eGFP) that is under control of the Itgax 
(or CD11c) promoter. Upon DT administration, CD11c+ 
cells containing this transgene are transiently depleted in most 
tissues (Jung et al., 2002).
In  control  DTR:WT  mice  injected  with  saline,  the   
majority of CD11c+ cells are GFP+, demonstrating reconsti-
tution of the lung with DTR-expressing cells (Fig. 2 A). 
Figure 2.  The presence of il12rb1/ DCs in the lung associates 
with impaired activation of M. tuberculosis-specific T cells in the 
draining MLN. Chimeras comprising 75% Itgax-DTR/EGFP:25% il12rb1+/+ 
or 75% Itgax-DTR/EGFP:25% il12rb1/ were injected with either PBS (A 
and F) or DT (B–E and G–J). 12 h later, the frequency of CD11c+ GFP+ and 
CD11c+ GFP cells remaining in the lungs after PBS injection (A and F)  
or DT injection (B and G) was determined. Gating based on CD11c+ GFP+ 
or CD11c+ GFP cells demonstrated the level of IL-12R1 surface expres-
sion (A and F). DT-injected mice subsequently received 1.5 × 106 CFSE-labeled 
ESAT6-specific CD4+ T cells i.v.  and 1 µg ESAT61-20/50 ng irradiated M. 
tuberculosis via the trachea. 12 h later, the frequency of CFSE+CD4+ cells 
in the draining MLN (C and H) and expression levels of the activation 
markers CD69 (D and I) and CD44 (E and J) determined by flow cytometry. 
The data points in K and L represent the CD44 (K) and CD69 (L) data from 
5 mice per group that received either 1 µg or 10 ng ESAT1-20 peptide with 
irradiated M. tuberculosis and are representative of two separate experi-
ments with 3–4 mice per group; for the difference in %CD44hi and 
%CD69+ ESAT-specific CD4+ cells between the indicated groups,  
*, P < 0.05; **, P < 0.005, as determined by Student’s t test.
 594 Splicing of il12rb1 alters DC migration | Robinson et al.
esis, we exposed il12b/ BMDC to M. tuberculosis and/or 
IL-12(p40)2 for 1 h, and, using electromobility shift assay 
Both  GFP+  and  the  subset  of  GFP  CD11c+  cells  are 
il12rb1+/+ and express basal levels of IL-12R1 on their sur-
face (Fig. 2 A). Upon injection of DT, the frequency of GFP+ 
CD11c+ cells drops 12-fold (Fig. 2 B), resulting in an in-
creased ratio of GFP to GFP+ CD11c+ cells. Treating the 
DTR:il12rb1/ mice with DT resulted in a similar drop in 
GFP+ CD11c+ cells (Fig. 2, F and G), and therefore a greatly 
reduced frequency of il12rb1+/+ CD11c+ relative to il12rb1/ 
CD11c+ cells in the lungs of these mice.
To compare the relative T cell–activating ability of lungs 
harboring a high frequency of il12rb1+/+ CD11c+ cells to 
those with a low frequency, we measured the response of   
antigen-specific cells in the MLN. To do this, we intrave-
nously transferred 1.5 × 106 CFSE-labeled ESAT-specific 
CD4+ T cells into DT-injected DTR:WT or DTR:il12rb1/ 
mice  immediately  before  instillation  via  the  trachea  of 
ESAT61-20 peptide and 1 µg of irradiated M. tuberculosis. 18 h 
later, the frequency of ESAT-specific T cells (Fig. 2, C and H) 
expressing markers of activation CD69 (Fig. 2, D and I) and 
CD44 (Fig. 2, E and J) in the draining MLN was determined. 
The frequency of ESAT6-specific T cells that expressed a 
high level of CD44 (Fig. 2 K) and CD69 (Fig. 2 L) in response 
to two different doses of antigen within the 18 h of the ex-
periment was significantly lower in the mice with a reduced 
frequency of il12rb1+/+ CD11c+ cells. Thus, an increase in 
the ratio of il12rb1/ to il12rb1+/+ DCs in the lungs is asso-
ciated with impaired activation of antigen-specific T cells in 
the draining MLN. These data demonstrate that il12rb1 ex-
pression in CD11c+ cells within the lung is required for 
M. tuberculosis–induced DC migration and induction of T 
cell activation in vivo.
IL-12(p40)2 initiates nuclear accumulation of NF-B in DCs
We wished to better understand the mechanism by which 
IL-12R1–dependent signaling modulates DC chemotaxis 
after exposure to M. tuberculosis. Lower levels of CCR7 (the 
receptor for CCL19) do not account for this result, as surface 
expression of CCR7 is similar between activated WT and 
il12rb1/ BMDCs (unpublished data). To determine if any 
intracellular signaling pathways that influence DC migration 
were altered in il12rb1/ DCs, we measured the phosphory-
lation levels of NF-B, SAPK/JNK, p38 MAP kinase, and 
STAT3 in these cells after stimulation with M. tuberculosis. 
We observed that stimulation of C57BL/6 DCs increases 
phospho-NF-B levels above those of unstimulated controls 
(Fig. 3, A and B). However, we consistently observed that 
levels of phospo-NF-B were lower in il12rb1/ DCs com-
pared with WT DCs at several time points, despite equiva-
lent levels of total NF-B (Fig. 3, C and D). No differences 
in phospho-SAPK/JNK, p38 MAP kinase, and STAT3 were 
observed between WT and il12rb1/ DCs (unpublished data). 
These data suggest that NF-B–dependent processes are 
compromised in il12rb1/ DCs
Because NF-B phosphorylation was defective in il12rb1/ 
DCs, we reasoned that NF-B binding should be enhanced 
when DCs are stimulated via IL-12R1. To test this hypoth-
Figure 3.  NF-B signaling is impaired in il12rb1/ DCs and can be 
promoted by IL-12(p40)2. (A-D) BMDCs generated from C57BL/6 and 
il12rb1/ mice were exposed to M. tuberculosis (B and D) or media alone 
(A and C) for the indicated times. After this period, cells were harvested 
under nondenaturing conditions and levels of total NF-B p65 (open bars) 
and phospho-NF-B p65 (closed bars) were determined by ELISA. Shown 
are the light absorbance values (A450) from one experiment that is represen-
tative of two experiments with separate BMDC preparations. (E) BMDCs 
were generated from il12b/ mice and exposed to media alone, M. tuber-
culosis, IL-12(p40)2, or both M. tuberculosis and IL-12(p40)2. 1 h later,  
nuclear extracts of the treated cells were isolated and EMSA of NF-B con-
sensus sequence-binding proteins was performed. Shown is a blot of NF-B 
consensus sequence-binding proteins from DCs stimulated with media 
alone (lanes 1 and 2), M. tuberculosis (lanes 3 and 4), both M. tuberculosis 
and IL-12(p40)2 (lanes 5 and 6) or IL-12(p40)2 alone (lanes 7 and 8). The 
absence () or presence (+) of a cold NF-B consensus probe was used to 
determine the specificity of each band.JEM VOL. 207, March 15, 2010 
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The mouse il12rb1 gene is located on autosomal chromo-
some 8 and comprises 16 exons (Fig. 4 A; NCBI protein   
database accession no. 16161). Upon transcription and intron 
removal,  exons  1–13  are  translated  into  the  extracellular   
portion of the IL-12R1 protein, whereas exon 14 and   
exons 15–16 are translated into the transmembrane and intra-
cellular portions, respectively (Fig. 4 B). To determine the 
transcription activity of this gene in DCs, we amplified cDNA 
from  BMDC  cultures  with  a  variety  of  primers  spanning   
different lengths of (cDNA) il12rb1 (Fig. 4 B). Amplification 
with  primers  (P)  recognizing  the  extracellular-encoding   
region (P1–P2) resulted in an amplicon (Fig. 4 C; cDNA 
from concanavalin-A–activated splenocytes is used as a posi-
tive control). Amplification of a more 3 region with primers 
P3–P5 also resulted in a PCR product in both unstimulated 
and  stimulated  DCs;  however,  under  these  amplification 
conditions a second smaller band was also observable, but 
only in DCs that had been stimulated with M. tuberculosis 
(Fig. 4 C, arrow). This second band does not appear upon 
amplification with primers that span the transmembrane- 
encoding region (P3-P4). Sequencing both the larger and 
smaller band amplified by primers P3–P5 revealed that the 
larger product represents (mRNA) il12rb1 and that the smaller 
product is identical, except for a 97-bp deletion (Fig. 4 D). 
This deletion has two effects: (1) deletion of the transmembrane 
(EMSA),  compared  the  amount  of  NF-B  consensus  se-
quence-binding proteins in nuclear extracts of the treated 
cells.  il12b/  BMDCs  were  used  for  this  experiment  to 
eliminate  potential  background  NF-B  activation  from   
endogenous IL-12(p40)2. Fig. 3 E demonstrates that the   
addition  of  M.  tuberculosis  to  DC  cultures  increases  the   
nuclear accumulation of NF-B over that seen in untreated 
BMDCs (Fig. 3 E, compare lanes 1 and 3). IL-12(p40)2 was 
also sufficient to increase the nuclear accumulation of NF-B 
over that seen in untreated BMDCs (Fig. 3 E, compare lanes 
1 and 7). The addition of both M. tuberculosis and IL-12(p40)2 
synergistically augmented NF-B activation above that of 
each stimulus alone (Fig. 3 E, compare lanes 3 and 7 to lane 
5). Thus, our data demonstrate that IL-12(p40)2 is able to 
stimulate NF-B nuclear migration in DCs. Consequently, 
the failure of il12rb1/ DCs to migrate (Figs. 1 and 2)   
associates with impaired NF-B–dependent gene activation.
BMDCs express (mRNA) il12rb1 and an (mRNA) il12rb1 
alternative splice variant after exposure to M. tuberculosis
The expression of (mRNA) il12rb1 by DCs has not been 
universally accepted because of an inability to reproducibly 
detect  this  transcript  (Grohmann  et  al.,  1998).  However, 
given the influence of il12rb1 on DC migration (Figs. 1 and 2), 
we reexamined (mRNA) il12rb1 expression in these cells. 
Figure 4.  DCs express an IL-12R1 alternative splice variant after exposure to M. tuberculosis. (A) The genomic position and organization of 
the murine il12rb1 locus. Exons 1–16 are denoted e.1-e.16. (B) Upon transcription and intron removal, e.1-13 become the extracellular-encoding (EC) 
portion of the IL-12R1 transcript, e.14 the transmembrane-encoding (TM) portion, and e15-16 the intracellular-encoding (IC) portion. Shown to the 
right of the transcript are the relative positions of primers 1–5 (P1-P5;  indicates a forward primer and  indicates a reverse primer) used for amplifi-
cation of IL-12R1 cDNA from the indicated cell populations (C). (D-E) Sequencing of the smaller amplicon of P3-P5 (indicated by arrow) reveals an IL-
12R1 alternative splice variant that contains both a 97-bp deletion and (E) a frameshift insertion that eventually produces a premature stop codon. This 
experiment has been repeated three times with three separate BMDC preparations.596 Splicing of il12rb1 alters DC migration | Robinson et al.
varying Y. pestis MOI (Fig. S2 I). Negative results were also 
obtained with TNF, IL-12, and IL-12(p40)2–stimulated DCs 
(Fig.  S2,  F–H).  Thus,  DCs  increase  the  expression  of 
il12rb1tm in response to M. tuberculosis and the related   
organism M. avium, but not upon stimulation with Gram-
negative Y. pestis, purified LPS, and cytokines TNF, IL-12, 
and IL-12(p40)2.
Human DCs respond to stimuli by splicing IL-12R1
After activation, human DCs increase surface expression of 
IL-12R1 (Nagayama et al., 2000). Two isoforms of the   
human IL-12R1 transcript are reported in publicly available 
databases: full-length IL-12RB1 (isoform 1; Swiss-Prot ID 
P42701-1) and a shorter isoform, missing the transmembrane 
domain and with an altered C-terminal amino-acid sequence 
that is the product of alternative splicing (isoform 2; Swiss-
Prot P42701-3; sequences available at http://www.uniprot.
org/uniprot/P42701; Fig. S3, A and B). To determine if hu-
man DCs splice the IL-12R1 transcript after stimulation in 
a manner that is analogous to mouse DCs, we exposed mono-
cyte-derived DCs to a variety of stimuli, some of which are 
sequence encoded by exon 14 and (2) a translational frame shift 
that results in an early stop codon. This translational frame shift 
also results in the loss of the Box1/2 signaling domains that are 
found in the IL-12R1 protein (van de Vosse et al., 2003). 
Both the nucleotide and deduced amino acid sequence of this 
smaller band (Fig. 4 E) match that of a previously reported 
alternative splice variant of the mouse IL-12R1 transcript 
(Chua et al., 1995). Thus, DCs respond to M. tuberculosis 
by expressing two species of (mRNA) il12rb1: a transmem-
brane-containing transcript (hereafter referred to as “(mRNA) 
il12rb1”) and an alternatively spliced variant of (mRNA) 
il12rb1 (hereafter referred to as “(mRNA) il12rb1tm”).
Kinetics of BMDC (mRNA) il12rb1tm expression  
after exposure to M. tuberculosis
As (mRNA) il12rb1tm was induced in BMDCs by M. tuber-
culosis,  we  wished  to  quantify  its  expression;  however,  it 
proved difficult to design a Taqman real-time PCR probe 
that recognized (cDNA) il12rb1tm and not (cDNA) il12rb1. 
Thus, to better quantify the kinetics of (mRNA) il12rb1tm 
expression  relative  to  (mRNA)  il12rb1  in  M.  tuberculosis–
stimulated DCs, we developed a PCR-based assay hereafter 
referred to as “IL-12R1 spectratype analysis.” IL-12R1 
spectratype  analysis  is  akin  to  TCR-CDR3  spectratype   
analysis (Pannetier et al., 1993) and is described in Fig. S1. 
When IL-12R1 spectratype analysis was applied to BMDCs, 
we  observed  a  dose-dependent  increase  in  the  ratio  of 
(mRNA) il12rb1tm to (mRNA) il12rb1 after a 3-h exposure 
to M. tuberculosis (Fig. 5 A). In contrast (mRNA) il12rb1  
remains the dominant transcript in unstimulated DCs for up 
to 6 h (Fig. 5 A). Western blot analysis demonstrated that   
IL-12R1 is the dominant protein product in unstimulated 
cells, whereas IL-12R1TM increases in abundance after 
M. tuberculosis stimulation (Fig. 5 B). That IL-12R1TM 
could locate in the membrane was indicated by Western blot 
analysis of cellular fractions (Fig. S1 H). Thus, analysis of 
mRNA  and  Western  blot  analysis  confirm  that  DCs   
increase the expression of il12rb1tm and production of   
IL-12R1TM after exposure to M. tuberculosis.
To assess the specificity of (mRNA) il12rb1 splicing in 
response to M. tuberculosis, we stimulated DCs with a variety 
of other microbial and cytokine stimuli. Specifically, DCs 
were stimulated with Mycobacterium avium and Yersinia pestis at 
an identical MOI, as well as with M. avium cell wall extract, 
Escherichia coli LPS, TNF, IL-12, and IL-12(p40)2; production 
of IL-12R1TM was subsequently assessed by IL-12R1 
Spectratype analysis. Both M. avium and Y. pestis were capa-
ble of activating DCs as measured by IL-12p40 production 
(Fig. S2 A). As shown in Fig. S2 B, over a 6-h incubation   
M. avium was capable of eliciting IL-12R1TM produc-
tion  with  kinetics  that  were  similar  to  that  elicited  by   
M. tuberculosis. This was also observed with M. avium cell wall 
extract (Fig. S2 C). Stimulation with Y. pestis and purified 
LPS (Fig. S2, D and E) failed to generate IL-12R1TM 
over the same 6-h period. Production of IL-12R1TM 
protein was also not observed after stimulation of DCs with 
Figure 5.  IL-12R1 Spectratype analysis of M. tuberculosis-activated 
DCs. (A) C57BL/6 BMDCs were stimulated over a period of 6 h with media 
alone or M. tuberculosis. Shown are representative IL-12R1 spectratype data 
from these DCs before culture (0 h) and after 1.5, 3, or 6 h of culture. The 
numbers adjacent to peaks of an individual IL-12R1 spectra indicate the 
relative ratio of that peak’s area (the smaller peak representing IL-12R1TM) 
to the area of the larger peak that represents IL-12R1. Spectra are represen-
tative of four BMDC cultures per condition; this experiment was performed 
twice. (B) Denaturing Western blot analysis of the same cells to confirm 
changing protein levels of IL-12R1 and IL-12R1TM; NIH/3T3 cells trans-
fected with the indicated plasmid constructs served as positive controls; blots 
were probed with polyclonal anti-IL-12R1.JEM VOL. 207, March 15, 2010 
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that  these  two  transcripts  were  differentially  expressed   
depending on the stimulus. Specifically, the production of 
isoform  2  was  strongly  associated  with  exposure  to  LPS,   
IL-1, IL-2, and CCL3. Stimulation of human DCs with M. 
tuberculosis also elicited expression of IL-12R1 isoform 2 
over a 6-h time course (Fig. S3 D). We conclude from these 
experiments that human DCs, like mouse DCs, respond to 
specific stimuli by splicing the IL-12R1 transcript.
known inducers of DC IL-12R1 expression (Nagayama 
et al., 2000). We then assessed the relative levels of transcripts 
for IL-12R1 isoforms 1 and 2 using specific primers; cDNA 
from CD3+ PBMCs was used as a positive control. All sam-
ples expressed IL-12R1 when assayed with primers that 
recognized both isoforms 1 and 2 (Fig. S3 C, top). However, 
amplification  with  primers  specific  to  either  isoform  1   
(Fig. S3 C, middle) or isoform 2 (Fig. S3 C, bottom) revealed 
Figure 6.  IL-12R1TM is expressed in the M. tuberculosis-infected lung. C57BL/6 mice were aerogenically infected with 100 CFU M. tuberculosis. 
At the indicated times after infection the lungs of both (A) uninfected and (B) infected mice were harvested for IL-12R1 spectratype analysis. Shown are 
representative spectra from (A) one individual uninfected mouse at each indicated time point or (B) two individual M. tuberculosis-infected mice from each 
time point. The numbers adjacent to peaks of an individual IL-12R1 spectra indicate the relative ratio of that peak’s area (the smaller peak representing  
IL-12R1TM) to the area of the larger peak that represents IL-12R1. (C) The ratio of IL-12R1TM to IL-12R1 expressed in the lung of uninfected and M. 
tuberculosis-infected animals. (D) The ratio of IL-12R1TM to IL-12R1 expressed in the liver of uninfected and M. tuberculosis-infected animals. Data points 
in C and D represent the mean and SD of the IL-12R1TM to IL-12R1 ratios expressed in 4–8 individual mice per time point and are combined from two 
separate experiments; for the difference between infected lungs relative to uninfected lungs, *, P < 0.05; **, P < 0.005, as determined by Student’s t test.598 Splicing of il12rb1 alters DC migration | Robinson et al.
il12rb1 was performed. As with M. tuberculosis, we observed a 
shift in the ratio of (mRNA) il12rb1tm to (mRNA) il12rb1 
(mRNAs) il12rb1 and il12rb1tm are expressed by CD11c+ 
cells in the M. tuberculosis–infected lung
We next asked whether (mRNA) il12rb1tm is expressed in 
response to M. tuberculosis infection in vivo. To assess this, a 
time course of (mRNA) il12rb1tm abundance relative to 
(mRNA) il12rb1 in mice aerogenically infected with M. tu-
berculosis was performed. In uninfected controls, the expres-
sion of (mRNA) il12rb1tm was minimal over the entire 
30-d period, with (mRNA) il12rb1 being the dominant tran-
script observed (Fig. 6 A). In M. tuberculosis–infected animals, 
however, a shift in the ratio of (mRNA) il12rb1tm to 
(mRNA) il12rb1 in the lung is observed at 9 d after infection 
(Fig. 6 B), with (mRNA) il12rb1tm reaching 2.3-fold higher 
in  abundance  than  (mRNA)  il12rb1  in  some  cases.  After   
9–12 d, the ratio of (mRNA) il12rb1tm to (mRNA) il12rb1 
in the lung diminished, but still remained higher than that of 
uninfected controls up to day 30. This result was observed in 
several independent experiments (Fig. 6 C). In the liver, an 
organ  distal  to  the  initial  site  of  infection,  we  observed   
elevated baseline levels of (mRNA) il12rb1tm expression 
compared with the lung (Fig. 6 D); however, these levels re-
mained unchanged through the early course of M. tuberculosis 
infection (Fig. 6 D). In summary, (mRNA) il12rb1tm is   
expressed subsequent to M. tuberculosis infection in vivo—the 
relative ratio to (mRNA) il12rb1 being dependent on time 
after infection.
The expression of IL-12R1TM by DCs in vitro (Fig. 5) 
and  by  the  M.  tuberculosis–infected  lung  in  vivo  (Fig.  6) 
prompted  us  to  determine  whether  CD11c+  cells  from   
M. tuberculosis–infected lungs are the source of this transcript. 
To do this, CD11c+ cells from the lungs of M. tuberculosis– 
infected mice were isolated by magnetic beads at various time 
points after infection and expression of (mRNA) il12rb1tm 
was determined as described in Fig. 6. CD11c+ cells from M. 
tuberculosis–infected mice consistently expressed a higher ratio 
of (mRNA) il12rb1tm to (mRNA) il12rb1 compared with 
those isolated from uninfected controls, the highest being   
observed  at  7–12  d  after  infection  (compare  top  panels  of   
Fig. 7, A and B). Notably, the CD11c cells from M. tubercu-
losis–infected mice also expressed a higher ratio of (mRNA) 
il12rb1tm to (mRNA) il12rb1 compared with uninfected 
controls, the highest being observed at 20 and 30 d after   
infection (compare bottom panels of Fig. 7, A and B). This 
result was observed in several independent experiments   
(Fig. 7 C-D). These data demonstrate that after low-dose 
aerogenic M. tuberculosis infection, lung CD11c+ cells exhibit 
increased expression of (mRNA) il12rb1tm and that CD11cneg 
cells can also express this transcript as infection progresses.
Similar to M. tuberculosis, M. avium and Y. pestis are lung-
tropic intracellular pathogens. Because exposure to M. avium, 
but  not  Y.  pestis,  increased  DC  expression  of  (mRNA) 
il12rb1tm, we next determined if (mRNA) il12rb1tm was 
also expressed in the M. avium– or Y. pestis–infected lung. For 
this, mice were aerogenically infected with M. avium (Fig. S4 A) 
or intranasally with Y. pestis KIMD27 (Fig. S4 C) and a time 
course of (mRNA) il12rb1tm abundance relative to (mRNA) 
Figure 7.  Lung CD11c+ and CD11c- populations increase  
IL-12R1TM expression after M. tuberculosis infection. C57BL/6 
mice were aerogenically infected with 100 CFU M. tuberculosis. At the 
indicated times after infection lung CD11c+ and CD11c- populations were 
magnetically separated from both (A) uninfected and (B) infected mice. 
Subsequently generated cDNA was used for IL-12R1 spectratype analy-
sis. Shown are representative spectra expressed by CD11c+ and CD11c- cells 
from (A) an individual uninfected mouse at each time point or (B) an indi-
vidual M. tuberculosis—infected mouse at each time point. The numbers 
adjacent to peaks of an individual IL-12R1 spectrum indicate the relative 
ratio of that peak’s area (the smaller peak representing IL-12R1TM) to the 
area of the larger peak that represents IL-12R1. Spectra are representative 
of four mice per time point. (C) The ratio of IL-12R1TM to IL-12R1 ex-
pressed by lung CD11c+ cells from uninfected and M. tuberculosis—infected 
animals. (D) The ratio of IL-12R1TM to IL-12R1 expressed by lung 
CD11c- cells from uninfected and M. tuberculosis-infected animals. Data 
points in (C and D) represent the mean and SD of the IL-12R1TM to IL-
12R1 ratios expressed in four individual mice per time point; for the differ-
ence between the indicated populations from infected lungs relative to 
uninfected lungs, *, P < 0.05, as determined by Student’s t test.JEM VOL. 207, March 15, 2010 
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that received sham electroporated il12rb1/ DCs had fewer 
activated M. tuberculosis–specific T cells in the draining MLN 
relative to those that received sham electroporated C57BL/6 
DCs (Fig. 8 E). Restoration of IL-12R1 alone to il12rb1/ 
DCs elevated the frequency of CD44hi and CD62Llo M. tu-
berculosis–specific T cells; however, restoring IL-12R1TM 
alone to il12rb1/ DCs did not elevate the frequency of   
activated M. tuberculosis-specific T cells. Importantly, only 
when both IL-12R1 and IL-12R1TM were restored to 
il12rb1/ DCs did the frequency of activated M. tuberculosis-
specific T cells return to the level seen in mice that received 
C57BL/6  DCs.  This  result  was  observed  across  several   
independent experiments (Fig. 8, F and G). These data dem-
onstrate  that  IL-12R1TM  can  enhance  IL-12R1– 
dependent DC migration from the lung and activation of M. 
tuberculosis–specific T cells in the lung draining MLN.
DISCUSSION
DCs are pivotal for initiating immunity to M. tuberculosis and 
other diseases of the pulmonary tract (Tian et al., 2005;   
Lambrecht, 2008), and they have been shown to transport   
M. tuberculosis from the lungs to the MLN (Wolf et al., 2007). 
IL-12 family members are secreted by DCs after Mtb stimu-
lation (Jang et al., 2008) and are required for their ability to 
generate an efficient T cell response (Zhang et al., 2003; 
Khader et al., 2006). Here, we demonstrate that after their 
encounter  with  M.  tuberculosis,  DCs  express  IL-12R1   
and  an  IL-12R1  splice  variant  that  we  have  termed   
“IL-12R1TM.” In contrast to IL-12R1, IL-12R1TM 
contains an altered C-terminal sequence and lacks a trans-
membrane  domain;  nevertheless,  IL-12R1TM  is  still 
membrane associated. Selective reconstitution of il12rb1/ 
DCs with IL-12R1 and/or IL-12R1TM demonstrates 
that  IL-12R1TM  augments  IL-12R1-dependent  DC 
migration; however, it cannot substitute for IL-12R1. Im-
portantly, after M. tuberculosis infection of the lung, CD11c+ 
cells in this organ express IL-12R1TM. Further, reconsti-
tution of il12rb1/ DCs with IL-12R1 and IL-12R1TM 
accelerates in vivo CD4+ T cell activation compared with 
il12rb1/ DCs reconstituted with IL-12R1 alone. Thus, 
we propose that in response to M. tuberculosis DCs express 
IL-12R1TM, a novel positive regulator of IL-12R1– 
dependent  signaling,  and  that  this  enhances  IL-12R1– 
dependent migration and M. tuberculosis–specific CD4+ T 
cell activation.
Alternative splicing is emerging as an important regulator 
of immunity (Lynch, 2004). It is estimated that >75% of   
human genes undergo alternative splicing, many of which are 
exclusively expressed by the immune system (Johnson et al., 
2003). The list of proteins regulated by splicing includes those 
involved in intracellular signaling cascades (i.e., Fyn and Syk), 
membrane adhesion (i.e., CD31, CD44, and CD54), and cell 
activation (i.e., CD45 and CD152; Lynch, 2004). Alterna-
tively spliced cytokine receptors can regulate inflammatory 
events by functioning as either agonists or antagonists of 
cytokine signaling (Levine, 2004). The list of alternatively 
in the lung at 8 d after infection with M. avium (Fig. S4 B). 
Despite similar numbers of CFU at 4 d after infection, only 
one out of five Y. pestis–infected animals showed expression 
of (mRNA) il12rb1tm (Fig. S4 D, top). Negative results 
were also obtained upon infection with the more immunos-
timulatory strain Y. pestis KIMD27/pLpxL (Robinson et al., 
2008; Fig. S4 D, bottom). Thus, although M. tuberculosis (Fig. 6) 
and M. avium induce expression of (mRNA) il12rb1tm in 
the lungs, Y. pestis does not.
IL-12R1TM enhances IL-12R1–dependent migration
DCs exhibit IL-12(p40)2– and il12rb1–dependent migration 
in response to M. tuberculosis after only a 3-h exposure to this 
organism (Fig. 1 C; Khader et al., 2006; Robinson et al., 
2008).  Given  that  (mRNA)  il12rb1tm  is  generated  and 
translated  within  this  timeframe  (Fig.  5),  we  investigated 
whether IL-12R1TM contributed to M. tuberculosis–
induced, IL-12(p40)2–dependent DC migration. To do this, 
we  selectively  restored  mRNAs  that  encode  IL-12R1,   
IL-12R1TM, or both IL-12R1 and IL-12R1TM to 
il12rb1/ DCs, which contain a genomic neo insertion that 
disrupts exons 1–3 of the il12rb1 locus (Wu et al., 1997) and 
thus lack both these proteins (Fig. 4). We co-transfected GFP 
encoding mRNA with the specific mRNAs via electropora-
tion and found that an antibody specific for the common ex-
tracellular  portion  of  the  IL-12R1  and  IL-12R1TM 
only  labeled  GFP+  CD11c+  cells  if  mRNAs  for  either   
IL-12R1  or  IL-12R1TM  were  delivered  to  the 
il12rb1/ DCs (Fig. 8, A and B). After stimulation with M. 
tuberculosis,  il12rb1/  DCs  transfected  with  GFP  and   
IL-12R1 were capable of migrating toward CCL19 whereas 
those transfected with GFP alone were not (Fig. 8 C). 
il12rb1/ DCs transfected with GFP and IL-12R1TM 
had migratory levels equivalent to those transfected with GFP 
alone. However, cotransfection with GFP, IL-12R1 and 
IL-12R1TM resulted in a greater chemotaxis index than 
when DCs were transfected with GFP and IL-12R1. The 
majority  of  migrated  cells  were  GFP+,  suggesting  that   
migration required transfection of the migrating cell and was 
not an indirect effect (Fig. 8 D). These data demonstrate   
that IL-12R1TM can enhance IL-12R1–dependent   
DC migration.
Finally, given that IL-12R1TM enhanced IL-12R1-
dependent DC migration in vitro, we determined whether 
its expression in DCs accelerated the activation of M. tubercu-
losis-specific T cells in vivo. il12rb1/ BMDCs were selec-
tively restored with mRNAs for IL-12R1, IL-12R1TM, 
or both IL-12R1 and IL-12R1TM as described in   
Fig. 8. After their electroporation and overnight culture, DCs 
were cultured with irradiated M. tuberculosis and ESAT1-20 
peptide for 3 h. After this period, DCs were washed and   
instilled via the trachea into the lungs of C57BL/6 mice that 
had previously received 5 × 106 CFSE-labeled ESAT-TCR 
CD4+ cells. 12 h after DC instillation, the surface expression 
of CD44 and CD69 by CFSE+CD4+ cells in the draining 
MLN was assessed by flow cytometry. As anticipated, mice 600 Splicing of il12rb1 alters DC migration | Robinson et al.
Figure 8.  IL-12R1TM enhances IL-12R1-dependent migration. (A–D) il12rb1/ CD11c+ BMDCs were transfected with mRNAs encoding ei-
ther GFP, GFP and IL-12R1, GFP and IL-12R1TM, or GFP and IL-12R1 and IL-12R1TM. 24 h later, (A) cells were analyzed by flow cytometry for 
GFP expression among CD11c+ cells and (B) expression of transfected IL-12R1 was examined by gating on GFP+CD11c+ cells. (C) The migratory ability of 
DCs transfected with the indicated mRNAs was assessed as performed in Fig. 1 C. Data points represent the mean and SD of the combined data from 
three separate experiments with different BM preparations per experiment. For the difference between CI induced in the indicated groups, *, P < 0.05, as 
determined by Student‘s t test. (D) Flow cytometric analysis of those cells that had migrated and transfected with GFP and IL-12R1 and IL-12R1TM 
demonstrates that the migratory DCs from this group were mostly GFP+. (E) We compared the ability of il12rb1/ DCs transfected with indicated mRNAs 
to activate M. tuberculosis-specific T cells in vivo; sham-transfected C57BL/6 DCs were used as a positive control. After transfection the indicated DCs JEM VOL. 207, March 15, 2010 
Article
601
IL-12R1–deficient DCs have a reduced M. tuberculosis–
dependent NF-B activation and that IL-12(p40)2 can induce 
NF-B activation alone and augment M. tuberculosis–dependent 
NF-B activation. Because it lacks any known intracellular 
signaling capacity, IL-12R1TM may enhance IL-12R1–
mediated NF-B activation by increasing the affinity of 
IL-12(p40)2 for IL-12R1 or by forming some other struc-
ture that favors IL-12(p40)2–dependent signaling. In particu-
lar, as IL-12p40 binds only to dimer/oligomers of IL-12R1 
(Chua et al., 1995), it is possible that the IL-12R1TM 
stabilizes oligomerization of IL-12R1. Although it is pos-
sible that the splice variant may be secreted into the superna-
tant, we have not been able to detect it in this fraction, even 
after 10-fold concentration, which leads us to postulate that 
the splice variant acts at the membrane. Future investigations 
in our laboratory will test this idea, as well as determine how 
IL-12R1TM  remains  membrane-associated  despite  the 
absence of a TM-domain.
A large body of data demonstrates the essential function 
that  the  IL12RB1  gene  serves  in  humans  to  positively   
regulate immunity to mycobacterial pathogens. The associa-
tion between IL12RB1 deficiency and mycobacterial suscep-
tibility undoubtedly reflects the importance of the IL12RB1 
gene  to  a  wide  variety  of  cell  types.  The  expression  of   
IL-12R1 mRNA is increased during active pulmonary   
tuberculosis in humans (Taha et al., 1999); expression of   
human IL-12R1TM during pulmonary tuberculosis has 
never been assessed. Although this study has focused on the 
importance of il12rb1 to DC function after their exposure to 
M. tuberculosis, our data present a novel pathway whereby a 
deficiency  in  IL-12R1TM  results  in  an  impaired  DC 
function and reduced T cell activation. The generation of a 
mouse specifically lacking IL-12R1TM but not IL-12R1 
is underway, and this will further our understanding of this 
important pathway.
MATERIALS AND METHODS
Mice. All mice were bred at the Trudeau Institute and were treated accord-
ing to National Institutes of Health and Trudeau Institute Animal Care and 
Use  Committee  guidelines.  All  animal  protocols  were  approved  by  the 
Trudeau Institute Animal Care and Use Committee. C57BL/6, B6.129S1-
Il12btm1jm/J (i.e., il12b/ mice; Magram et al., 1996), B6.129S1-Il12rb2tm1jm/J 
(i.e.,  il12rb2/  mice;  Wu  et  al.,  2000),  and  B6.FVB-Tg(Itgax-DTR/
EGFP)57Lan/J (i.e., CD11c-DTR; Jung et al., 2002) mice were originally 
purchased from The Jackson Laboratory. C57BL/6 mice deficient of the 
B6.129S1-Il12rb2tm1jm/J (il12rb1/ mice) have been previously described 
(Wu et al., 1997), as have ESAT61-20-specific TCR-transgenic mice (Reiley 
et al., 2008).
Cell preparations. M. tuberculosis infections were performed and the lung 
tissue  and  lymph  nodes  were  processed  as  described  previously  (Khader   
et al., 2007). Single-cell suspensions were prepared from either digested lung 
spliced cytokine receptors include members of the class I   
cytokine receptor superfamily (IL-4R, IL-5R, IL-6R, IL-
7R, IL-9R, EpoR, GCSFR, GMCSFR, gp130, and LIFR), 
class  II  cytokine  receptor  superfamily  (IFNAR1  and  IF-
NAR2), IL-1/TLR family (IL-1RII and IL-1RAcP), TGF 
receptor family (TRI and activin receptor-like kinase 7), and 
TNFR  superfamily  (TNFRSF6/Fas/CD95,  TNFRSF9/ 
4-1BB/CD137, and IL-17R; Levine, 2004).
To this list of spliced and functioning cytokine receptors 
we can now add IL-12R1TM. The mouse IL-12R1 and 
IL-12R1TM  cDNAs  were  originally  cloned  based  on 
their nucleotide homology to human IL-12R1 (Chua et al., 
1995). When transfected into COS cells, both cDNAs pro-
duced proteins that bind [125I]IL-12 with similar low affini-
ties,  suggesting  that  IL-12R1  and  IL-12R1TM  were 
both  expressed  on  the  cell  surface  (Chua  et  al.,  1995).   
However,  no  function  had  or  has  been  ascribed  to  IL-
12R1TM since that time. Here, we have demonstrated 
that although mouse IL-12R1TM cannot substitute for 
IL-12R1, it can function in DCs to enhance IL-12(p40)2– 
and IL-12R1–dependent migration. That this may be rele-
vant to our understanding of human DC biology is suggested 
by our observation that human PBMC-derived DCs also re-
spond to stimulation by splicing (mRNA) IL12RB1 to gen-
erate  a  protein  with  similar  characteristics  as  the  mouse 
variant. Curiously, for humans, the stimuli that elicit (mRNA) 
IL12RB1  splicing  are  broader  in  origin  than  for  mice. 
Whether human IL-12R1TM performs the same func-
tion in human DCs should certainly be investigated. It should 
be mentioned that IL-12R1TM expression is likely not 
restricted to DCs and may augment functions other than mi-
gration. The expression of (mRNA) il12rb1 and (mRNA) 
il12rb1tm  in  the  CD11cneg  fraction  of  M.  tuberculosis– 
infected lungs suggests that the proteins encoded by these   
sequences may play a role during the chronic stage of infec-
tion.  Whether  IL-12R1TM  functions  to  enhance   
IL-12R1–dependent processes in T and NK cells is a focus 
of future investigations.
Further questions raised by the data include which signal-
ing pathways are required in order for (mRNA) IL-12R1 
to be spliced? Our data demonstrate that for mouse DCs, 
both M. tuberculosis and M. avium elicit (mRNA) IL-12R1 
splicing, whereas Y. pestis stimulation does not; this despite 
the fact that Y. pestis does induce DC migration (Robinson et 
al., 2008). This suggests that although induction of (mRNA) 
il12rb1 is sufficient for DC migration, the augmented migra-
tion resulting from induction of (mRNA) il12rb1tm is a 
unique aspect of mycobacterial activation of DCs. We have 
begun  to  address  the  molecular  mechanism  by  which   
IL-12R1TM  augments  DC  migration  and  show  that   
populations were cultured with M. tuberculosis and ESAT1-20 peptide; after this they were instilled via the trachea into C57BL/6 mice containing trans-
ferred CFSE-labeled ESAT-specific CD4+ cells. Shown are histograms of CD44 and CD69 expression on CFSE+CD4+ 12 h later in the draining MLN. Each 
histogram is representative of four mice per condition. (F and G) The combined (F) CD44 and (G) CD69 data gated on CFSE+CD4+ in the draining MLN are 
shown; these data are representative of two independent experiments with three to four mice per group.
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resuspended at 20 × 106 cells/ml in cDMEM, and 1 ml of splenocytes 
was plated in 6-well dishes (Corning, Inc.) along with 1 ml of 10 µg/ml   
Concanavalin A in cDMEM solution (Sigma-Aldrich) for a final concentration 
of 5 µg/ml Concanavalin A. Cultures were maintained at 37°C at 10% CO2 
for 3 d before cells were harvested for RNA and/or protein as indicated.
RNA purification and cDNA synthesis. Total RNA was isolated from 
indicated  tissues  and/or  cell  populations  using  the  RNeasy  method   
(QIAGEN) and was treated with DNase (Ambion). cDNA was subsequently 
synthesized using SuperScript II reverse transcription PCR kit (Invitrogen) 
with random hexamer primers.
PCR.  To  amplify  the  IL-12R1  transcript,  we  used  primer  pairs  that   
selectively amplify the extracellular, transmembrane, or intracellular encod-
ing portions. The relative positions of these primers (labeled P1-P6) are   
illustrated in Fig. 3 B. P1–4 sequences are taken directly from a previous 
study of IL-12R1 expression in DCs (Grohmann et al., 1998). The 5-3 
sequences of these and the other primers used in our study are as follows: P1, 
5-TATGAGTGCTCCTGGCAGTAT-3; P2, 5-GGCATGCTCCAAT-
CACTCCAG-3;  P3,  5-AATGTGCTCGCCAAAACTCG-3;  P4,  5-
GCCAATGTATCCGAGACTGC-3. Primer P5 was designed for this 
study; its sequence is as follows: 5-CTGCCTCTGCCTCTGAGTCT-3. 
IL-12R1 transcripts were amplified by PCR in a 25-µl reaction comprising 
the following: 2.5 µl of a 10× PCR buffer (200 mM Tris, pH 8.4, 500 mM 
KCl), 0.5 µl of 10 mM dNTPs, 1 µl 50 mM MgCl2, 0.1 µl of 5 U/µl Taq 
polymerase (Invitrogen), 1 µl of 5 µM forward primer (P1 or P3), 1 µl of 
5 µM reverse primer (P2, P4 or P5), 17.9 µl of DNase-free H2O, and 1 µl of 
cDNA (a minimum of 200 pg cDNA). After denaturation at 94°C for 3 min, 
the reaction was cycled forty times under the following conditions: 94°C for 
45 s, 60°C for 30 s, and 72°C for 90 s. The products of this reaction were 
analyzed on a 2% agarose gel or kept for IL-12R1 spectratype analysis as 
described in the following section.
IL-12R1  spectratype  analysis.  IL-12R1  spectratype  analysis  of   
IL-12R1  and  IL-12R1TM  mRNAs,  and  the  quantification  of  the   
resultant data, was a modification of the now commonly used TCR-CD3 
Spectratype analysis (Pannetier et al., 1993). IL-12R1 and IL-12R1TM 
cDNA transcripts were first amplified by PCR in the 25-µl reaction detailed 
above with the forward primer 5-CAGCCGAGTAATGTACAAGG-3 
and reverse primer 5-CTGCCTCTGCCTCTGAGTCT-3. The forward 
primer corresponds to nt 1653–1672 of the mouse IL-12R1 transcript and 
precedes the transmembrane-encoding sequence (nt 1739–1834). The   
reverse primer is downstream of the transmembrane-encoding sequence, 
corresponding to nucleotides 2067–2086 of the mouse IL-12R1 transcript. 
To fluorescently label the IL-12R1 and IL-12R1TM amplicons we 
performed a second, runoff PCR reaction as follows: 2.5 µl of the initial   
amplification reaction was added to 22.5 µl of a second PCR comprising 
2.5 µl of 10× PCR buffer, 0.5 uL of 10 mM dNTPs, 1 uL 50 mM MgCl2, 
0.1 uL of 5 U/uL Taq polymerase (Invitrogen), 2 uL of a 5 uM FAM-labeled 
reverse primer (FAM-5-AGTGCTGCCACAGGGTGTA-3), and 16.4 µl 
of DNase-free H2O (final volume: 25 µl). After denaturation at 94°C for 
5 min, the reaction was cycled four times under the following conditions: 
95°C for 2 min, 55°C for 2 min, 72°C for 20 min. 2 µl of the completed 
runoff PCR reaction was then added to 2.0 µl of ROX-500 size standard 
(Applied Biosystems) and 36 µl of HiDi Formamide (Applied Biosystems). 
After denaturation, the products were detected and their size and relative 
amount determined using an Applied Biosystems 3100 sequencer analyzed 
with GeneScan software (Applied Biosystems). For calculating the ratio of 
IL-12R1TM to IL-12R1 (i.e., IL-12R1TM:IL-12R1) we simply 
divided the area under the IL-12R1TM peak by the area under the   
reference IL-12R1 peak.
Plasmids  and  transfections.  Plasmids  expressing  IL-12R1  and   
IL-12R1TM cDNAs in vector pEF-BOS (Mizushima and Nagata, 1990) 
under  the  EF1  promoter  have  been  described  (Chua  et  al.,  1995;   
tissue or lymph nodes by direct dispersal through a 70-µm nylon tissue 
strainer (BD). The resultant suspension was treated with Geys solution (155 
mM NH4Cl, 10 mM KHCO3) to remove any residual red blood cells, 
washed twice with complete media, counted, and stained for subsequent 
flow cytometric analysis.
BMDCs. BMDCs were generated from BM of 4–5-wk-old C57BL/6 mice 
harvested via perfusion of the femur and tibia medullary cavities with ice 
cold DMEM. Marrow suspensions were pelleted and incubated in Geys   
solution  to  lyse  red  blood  cells,  and  the  marrow  was  then  resuspended   
at 4 × 105 cells/ml in complete supplemented DMEM (cDMEM). 5 ml of 
BM homogenate was plated in a Petri dish (Corning, Inc.) along with 5 ml 
of 40 ng/ml recombinant murine GM-CSF (Peprotech) in cDMEM solu-
tion for a final concentration of 20 ng/ml GM-CSF. Cultures were main-
tained at 37°C at 10% CO2 for 3 d, at which time an additional 10 ml of 
20 ng/ml GM-CSF in cDMEM was added. At 6 d, nonadherent cells were 
collected and the presence of CD11c+ cells confirmed by flow cytometric 
analysis. For indicated experiments CD11c+ cells were positively selected by 
magnetic purification. In these cases 106 CD11c+ cells were placed in a 2 ml 
culture  with  or  without  indicated  concentrations  of  M.  tuberculosis,   
Y. pestis, M. avium, TNF, IL-12, or IL-12(p40)2 in cDMEM for varying 
amounts of time at 37°C and 10% CO2. After this period, cells were   
collected and either lysed for RNA and/or protein as indicated or used for 
chemotaxis measurements.
Flow cytometry. All antibodies used for flow cytometric analysis were 
purchased from BD or eBioscience. Experimental cells were washed with 
FACS buffer (2% FCS in PBS), FC receptors were blocked using anti-CD16/
CD32 (BD; clone 2.4G2) for 15 min and cells were stained with antibodies 
that recognize CD11c (clone HL3), I-Ab (clone AF6-120.1), and IL-12R1 
(CD212, clone 114). For all surface markers, positive staining was established 
using appropriate isotype controls. Data were acquired using a FACSCalibur 
(BD) and analyzed with FlowJo software (Tree Star, Inc.).
In vitro chemotaxis measurement. BMDCs were activated with indi-
cated concentrations of irradiated M. tuberculosis and their ability to respond 
to the chemokine CCL19 (25 ng/ml; R&D Systems) was determined using 
the previously described in vitro transwell chemotaxis assay (Khader et al., 
2006).
In vivo tracking of lung CD11c+ DCs. C57BL/6, il12b/, il12rb1/, and 
il12rb2/ mice received a suspension of 5 µg of irradiated M. tuberculosis in a   
5-mM CFSE (Invitrogen) solution delivered via the trachea. 18 h after instilla-
tion,  the  draining  MLNs  were  harvested,  and  single-cell  suspensions  were   
prepared. Flow cytometry was used to determine the frequency and total   
number of CFSE-labeled CD11c+ cells that had accumulated within the MLN.
BM  chimeras.  To  generate  mice  in  which  only  CD11c+  cells  were   
deficient of il12rb1, we generated mixed BM chimeras comprising of irradi-
ated C57BL/6 hosts reconstituted with 75% CD11c-DTR/25% il12rb1/ 
BM. Intraperitoneal injection of DT (resuspended in sterile PBS) should 
theoretically remove CD11c+ cells expressing the DTR leaving in this case 
only il12rb1/ CD11c+ cells. In brief, 6–10 wk old C57BL/6 hosts were 
lethally irradiated with 950 Rads (i.e., a split dose of 475 Rads each, 4 h 
apart). The irradiated hosts then received 107 whole BM donor cells com-
prising  either  75%  CD11c-DTR/25%  il12rb1/  BM  or  75%  CD11c-
DTR/25% C57BL/6 BM as a control. BM was prepared as described in the 
BMDCs section. Mice were allowed at least 6 wk to reconstitute. Before 
ESAT1-20/M. tuberculosis instillation, all mice received an i.p. injection of 
4 ng DT/g of body mass to ablate DTR-transgenic CD11c+ cells.
Cell culture. For the generation of Concanavalin A blasts, C57BL/6 spleens 
were dispersed through a 70-µm nylon cell strainer (BD) and the cellular 
homogenate was pelleted (270 g, 6 min at 4°C) and resuspended in 2 ml of 
Geys solution to remove red blood cells. Splenocytes were washed and   JEM VOL. 207, March 15, 2010 
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In vivo migration of electroporated DCs. After mRNA electroporation 
and overnight culture, 106 DCs were cultured with 10 µg/ml irradiated   
M. tuberculosis and 1 µM ESAT1-20 peptide for 3 h. After this time the DCs 
were washed, resuspended in PBS, and instilled via the trachea into the lungs 
of C57BL/6 mice. 18 h before instillation, each mouse had intravenously 
received  5  ×  106  CFSE-labeled  ESAT-TCR  CD4+  cells.  The  surface   
expression of CD44 and CD69 on CFSE+CD4+ cells in the draining MLNs 
was assessed 12 h later by flow cytometry.
IL-12RB1 isoform expression by human DCs. Monocyte-derived DCs 
were generated by incubating magnetically purified CD14+ monocytes from 
apheresis  samples  for  7  d  with  20  ng/ml  GMCSF  (Peprotech)  and   
50 ng/ml IL-4 (R&D Systems). DCs were then incubated for 24h with 1 
µg/ml LPS or for 3 d with either of the following: 10 ng/ml IL-1, 200 ng/ml 
IL-10, 10 ng/ml IL-6, 20 U/ml IL-2, 50 ng/ml CCL3, 50 ng/ml PlGF, or 
just RPMI media (control). Alternatively, DCs were stimulated with M. tu-
berculosis over a 6-h period. Subsequently generated cDNA from these popu-
lations  was  then  amplified  with  primer  pairs  that  either  amplified  both 
IL-12RB1 isoforms 1 and 2 (Common: forward, 5-ACACTCTGGGTG-
GAATCCTG-3; reverse, 5-GCCAACTTGGACACCTTGAT-3), only 
isoform 1 (Isoform 1 Specific: forward, 5-ACACTCTGGGTGGAATC-
CTG-3; reverse, 5-CACCCTCTCTGAGCCTCAAC-3) or only isoform 
2 (Isoform 2 Specific: forward, 5-ACACTCTGGGTGGAATCCTG-3; 
reverse, 5-CACTTTGGGAGGCCAAG-3). The conditions used to am-
plify with these primers were the same as those used for the primary PCR of 
IL-12R1 spectratype analysis detailed above. cDNA from CD3+ PBMCs 
was used as a positive control for IL-12RB1 expression. Amplicons were 
analyzed by 2% agarose gel electrophoresis.
Statistical analysis. Differences between the means of experimental groups 
were  analyzed  with  the  two-tailed  Student’s  t  test  as  the  data  were   
considered parametric. Differences with a P value of 0.05 or less were   
considered significant. Prism software was used for all analyses.
Online supplemental material. Fig. S1 demonstrates the concept and 
validation  of  IL-12R1  spectratype  analysis.  Fig.  S2  shows  that  the   
expression of IL-12R1TM mRNA by mouse DCs is limited to myco-
bacterial stimulation. Fig. S3 demonstrates that two isoforms of IL-12R1 
are expressed by human DCs after exposure to M. tuberculosis and other 
specific  stimuli.  Fig.  S4  shows  that  lung  expression  of  IL-12R1TM 
mRNA also occurs during pulmonary infection with M. avium, but not 
Y. pestis. Online supplemental material is available at http://www.jem.org/ 
cgi/content/full/jem.20091085/DC1.
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